Schick Technologies
This article was originally published in The Gray Sheet
Executive Summary
Nasdaq delisting notice is received by the maker of digital radiographic imaging systems for the dental and medical markets based on its inability to timely file its form 10-K annual report for the fiscal year ended March 31 and other factors. A review of the decision will be requested. PricewaterhouseCoopers resigned Aug. 25 as the firm's independent auditor and Schick subsequently retained Grant Thornton LLP as a replacement. At the time of PWC's resignation, the company accounting firm had not yet completed its year-end audit of the company's financial statements. Consulting firm Zolfo Cooper, LLC also has been retained to advise the firm on its profit and cost structure strategies
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.